Modulation of Amidase to Develop New Dosage Forms of Anti-Tuberculosis Drugs without Hepatotoxicity and Application of Genetic Polymorphisms of Metabolic Enzymes in Early Diagnosis of Anti-Tuberculosis Drug-Induced Hepatotoxicity
博士 === 國防醫學院 === 生命科學研究所 === 102 === Anti-tuberculosis drug-induced hepatotoxicity (ATDIH) is the most common adverse drug reaction caused by first-line anti-TB drugs, i.e. isoniazid (INH), pyrazinamide (PZA) and rifampin (RIF). Among them, INH is the most potent single agent against TB but is also...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/00168798383565075563 |
